Heron Therapeutics

CINVANTI

Manufacturer:

Heron Therapeutics

Cinvanti HCPCS:

J0185

HCPCS Code Descriptor:

Injection, aprepitant, 1 mg

Category:

J Code

Cinvanti NDCs:

47426-0201-01

Primary Type:

Oncology-Anti-Emetic

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Cinvanti CPT Codes:

Potential CPT administration codes for Cinvanti can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Cinvanti:

CINVANTI is an Oncology-Anti-Emetic drug manufactured by Heron Therapeutics and administered via the Intravenous route of administration. The J Code: J0185 is aligned to the drug CINVANTI.

ACCESS PRICING AND MORE BY REGISTERING

J0185 Added Date:

January 1, 2019

J0185 Effective Date:

January 1, 2019

J0185 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Cinvanti billing and coding information.
Cinvanti patient assistance information can be found through Heron Connect at the URL: https://www.heronconnect.com/CINVANTI/Programs-and-Enrollment
CINVANTI prescribing information can be found at the link below:
Information regarding CINVANTI’s side effects can be found at MedlinePlus